Achievements
in
Plant
Biotechnology
2000

"Responsible biotechnology is not the enemy; starvation is."
Jimmy Carter, former President of the United States, Houston Chronicle,
10-22-00 |
Introduction
The Year in Review
Worldwide Progress
The year 2000 marked the fifth anniversary of the commercialization of
major field crops enhanced through biotechnology. According to the International
Service for the Acquisition of Agri-biotech Applications (ISAAA), commercial
plantings of these crops reached 109.3 million acres worldwide - an increase
of 11 percent over 1999. Interestingly, the acres devoted to biotechnology
crops in developing countries increased 51 percent in 2000, compared to
an increase of 2 percent in industrial nations. The United States remained
the world's largest producer of enhanced crops with about 75 million acres
planted in 2000, while Argentina, Canada and China ranked second through
fourth.
The potential of biotech
crops to enhance food and feed yields, reduce the use of chemical inputs
and increase farmer profitability is the reason why the world's growers
plant these crops more widely every year. In fact, crops that protect
themselves against herbicides and harmful insects already have made a
significant impact on farmer profitability, according to grower surveys
conducted in 2000.
Monsanto Highlights
- 2000
In 2000, Monsanto continued to offer the world's growers the most advanced
agricultural technologies, the widest coverage in both crops and geography,
and a portfolio of products unmatched in the industry. Through our development
of plant biotechnology, we are helping our customers manage the financial
challenges of farming by improving their yields and reducing their input
costs. We're also helping them farm in a more environmentally sustainable
manner.
In 2000:
-
Acres planted with
Monsanto traits grew by 15 percent over 1999, and seeds with Monsanto
traits accounted for 90 percent of the acres planted with herbicide
tolerant or insect-protected crops.
-
For the first time,
YieldGard insect-protected corn was grown commercially
in Germany, and YieldGard/Roundup Ready stacked
trait corn was grown commercially in the U.S.
-
We conducted more
than 800 field trials for regulatory and efficacy purposes in North
America (U.S., Canada), Latin America (Argentina, Mexico,
Chile, Columbia, Guatemala, Honduras), Asia (China, Indonesia,
Thailand, Philippines, Japan, India, Australia, New Zealand), Africa
(South Africa), Eastern Europe (Romania, Czech Republic, Poland,
Hungary, Ukraine, Russia, Bulgaria) and the Middle East (Turkey
and Israel).
-
We received U.S.
regulatory approval for a second generation Roundup Ready corn
product; India approved seed bulk-up and demo trials for insect-protected
cotton; Roundup Ready soybeans received import approval from
Poland, Korea, Russia and Thailand, and the European Union Scientific
Committee for Plants issued a favorable recommendation for Roundup
Ready corn.
-
Grower satisfaction
with Monsanto's biotech crops remained high. For instance, about 96
percent of surveyed U.S. Roundup Ready corn growers and more
than 95 percent of surveyed U.S. Roundup Ready soybean growers
reported satisfaction with our products.
-
Monsanto's biotech
crops continued to add value to farming compared to conventional crops.
Surveyed U.S. growers reported an economic benefit of $14.08 per acre
from our Roundup Ready soybean system and $13.54 per acre from
YieldGard corn.
-
Roundup Ready
cotton, corn and soybeans - including our new Residue Proven Roundup
Ready soybeans - are helping to increase the use of conservation
tillage (con-till) techniques, worldwide. In 2000, Roundup herbicide
was used on about 257 million con-till acres - two-thirds of the world's
total.
-
To help address
Vitamin A deficiency among people whose staple food is rice, we made
our rice genome sequence data available for public use. By October 2000,
more than 200 scientists around the world had registered to access our
data.
All
italicized product names in this publication indicate trademarks or servicemarks
of Monsanto Company or its subsidiaries.
|
|